Abstract
Objectives
The objective of this review was to evaluate the evidence from human studies on the intake of vitamins, either as monotherapies or in combination with other vitamins, as neuroprotective agents that may delay the onset of cognitive decline in older adults.
Methods
Evidence-based methodologies were used to capture and evaluate the highest levels of evidence.
Findings
The current evidence available showed no association for cognitive benefits of vitamins B6 or B12 as a monotherapy, and recent systematic reviews provide no clear evidence that supplementation with vitamin B6, B12 and/or folic acid improves dementia outcomes or slows cognitive decline, even though it may normalise homocysteine levels. Meta-analyses from systematic reviews have shown an association between low vitamin D levels and diminished cognitive function, although causality cannot be confirmed from the available evidence. There is no convincing evidence for an association of vitamin A, vitamin C or vitamin E either as a monotherapy or in combination with other antioxidant vitamins such as β-carotene and the prevention of cognitive decline. The appraisal of nineteen systematic reviews and meta-analyses has highlighted the heterogeneity between studies, and the need for better consensus on definitions of cognitive decline, duration of testing and agreement on which specific endpoints are clinically relevant.
Conclusions
Evaluation of the totality of the currently available evidence indicates that intake of the above vitamins, either as a monotherapy, or in combination with other vitamins, has no clinically-relevant effect on delaying cognitive decline or delaying the onset of dementia in older adults.
Similar content being viewed by others
Abbreviations
- 25OHD:
-
25-hydroxyvitamin D
- AD:
-
Alzheimer’s Disease
- ADAS-cog:
-
Alzheimer’s Disease Assessment Scale-Cognitive Subscale
- AIBL:
-
Australian Imaging, Biomarkers and Lifestyle study
- CAMCOG:
-
Cambridge Cognitive Examination
- CHAP:
-
Chicago Healthy Aging Project
- CDR:
-
Clinical Dementia Rating Scale
- CSF:
-
Cerebrospinal fluid
- DARE:
-
Database of review of effects
- HC:
-
Healthy control
- holoTC:
-
Holotranscobalamin
- IOM:
-
Institute of Medicine
- JBI:
-
Joanna Briggs Institute (JBI)
- MCI:
-
Mild cognitive impairment
- MMA:
-
Methyl malonic acid (MMA)
- MMSE:
-
Mini-Mental State Examination
- NHMRC:
-
National Health and Medical Research Council
- NHS EED:
-
National Health Service Economic Evaluation Database
- PIB-PET:
-
Pittsburgh compound B Positron Emission Tomography
- PLP:
-
pyridoxal phosphate
- RCT:
-
Randomised controlled trial
- TICS:
-
Telephone Interview of Cognitive Status
- RR:
-
Relative risk
- SMD:
-
Standardised mean difference
- UVB:
-
Ultraviolet B
- VITACOG:
-
Homocysteine and B vitamins in cognitive impairment RCT study
- WMD:
-
Weighted mean difference
References
Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. Preventing Alzheimer’s disease and cognitive decline. Agency for Healthcare Research and Quality 2010:AHRQ Publication No. 10-E005, April 2010.
Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T. Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis. Alzheimers Dement 2014;10(4):485–502.
Rodriguez-Martin JL, Qizilbash N, Lopez-Arrieta JM. Thiamine for Alzheimer’s disease. Cochrane Database Syst Rev 2001(2):CD001498.
van de Rest O, van Hooijdonk LWA, Doets E, Schiepers OJG, Eilander A, de Groot L. B Vitamins and n-3 Fatty Acids for Brain Development and Function: Review of Human Studies. Ann Nutr Metab 2012;60(4):272–292.
Riviere S, Birlouez-Aragon I, Nourhashemi F, Vellas B. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 1998;13(11):749–754.
Agbayewa MO, Bruce VM, Siemens V. Pyridoxine, ascorbic acid and thiamine in Alzheimer and comparison subjects. Can J Psychiatry 1992;37(9):661–662.
Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, Cecchetti R, Baglioni M, Simmons A, Soininen H, Tsolaki M, Kloszewska I, Vellas B, Lovestone S, Mecocci P. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging 2012;33(10):2282–2290.
Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, Beauchet O. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009;16(10):1083–1089.
Pogge E. Vitamin D and Alzheimer’s disease: is there a link? Consult Pharm 2010;25(7):440–450.
Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, Seibel MJ, Mason RS. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012;196(11):686–687.
Mucke L. Alzheimer’s disease. Nature 2009;461(15):895–897.
NHMRC. How to use the evidence: assessment and application of scientific evidence. National Health and Medical Research Council (NHMRC), Commonwealth of Australia 2000.
Malouf R, Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 2003(4):CD004393.
Malouf R, Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev. 2003/08/15 ed, 2003:CD004394.
McCracken C. Challenges of long-term nutrition intervention studies on cognition: discordance between observational and intervention studies of vitamin B12 and cognition. Nutr Rev 2010;68:Suppl. 1, S11–15.
Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012;24(4):541–556.
Doets EL, van Wijngaarden JP, Szczecinska A, Dullemeijer C, Souverein OW, Dhonukshe-Rutten RAM, Cavelaars A, van ‘t Veer P, Brzozowska A, de Groot L. Vitamin B-12 Intake and Status and Cognitive Function in Elderly People. Epidemiol Rev 2013;35:2–21.
O’Leary F, Allman-Farinelli M, Samman S. Vitamin B-12 status, cognitive decline and dementia: a systematic review of prospective cohort studies. Br J Nutr 2012;108(11):1948–1961.
Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008(4):CD004514.
Bhat RS. You are what you eat: of fish, fat and folate in late-life psychiatric disorders. Curr Opin Psychiatry 2009;22(6):541–545.
Buhr G, Bales CW. Nutritional supplements for older adults: review and recommendations—Part II. J Nutr Elder 2010;29(1):42–71.
Hinterberger M, Fischer P. Folate and Alzheimer: when time matters. J Neural Transm 2013;120(1):211–224.
Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007;167(1):21–30.
Raman G, Tatsioni A, Chung M, Rosenberg IH, Lau J, Lichtenstein AH, Balk EM. Heterogeneity and Lack of Good Quality Studies Limit Association Between Folate, Vitamins B-6 and B-12, and Cognitive Function. J Nutr 2007;137(7):1789–1794.
Jia X, McNeill G, Avenell A. Does taking vitamin, mineral and fatty acid supplements prevent cognitive decline? A systematic review of randomized controlled trials. J Hum Nutr Diet 2008;21(4):317–336.
Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B. B-Vitamins and Fatty Acids in the Prevention and Treatment of Alzheimer’s Disease and Dementia: A Systematic Review. J Alzheimers Dis 2010;22(1):205–224.
Wald DS, Kasturiratne A, Simmonds M. Effect of Folic Acid, with or without Other B Vitamins, on Cognitive Decline: Meta-Analysis of Randomized Trials. Am J Med 2010;123(6):522–529.
Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012;29(1):133–149.
Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, Llewellyn DJ, Raina P. Vitamin D, cognition, and dementia: a systematic review and metaanalysis. Neurology 2012;79(13):1397–1405.
Etgen T, Sander D, Bickel H, Sander K, Forstl H. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement Geriatr Cogn Disord 2012;33(5):297–305.
Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-Analysis of Memory and Executive Dysfunctions in Relation to Vitamin D. J Alzheimers Dis 2013;37(1):147–171.
van der Schaft J, Koek HL, Dijkstra E, Verhaar HJ, van der Schouwaa YT, Emmelot-Vonk MH. The association between vitamin D and cognition: A systematic review. Ageing Res Rev 2013;12(4):1013–1023.
Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2013;33(3):659–674.
Zhao Y, Sun Y, Ji HF, Shen L. Vitamin D levels in Alzheimer’s and Parkinson’s diseases: a meta-analysis. Nutrition 2013;29(6):828–832.
Farina N, Isaac MG, Clark AR, Rusted J, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database Syst Rev 2012(11):CD002854.
Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer’s disease and mild cognitive impairment. Cochrane Database Syst Rev 2008(3):CD002854.
Li FJ, Shen L, Ji HF. Dietary Intakes of Vitamin E, Vitamin C, and beta- Carotene and Risk of Alzheimer’s Disease: A Meta-Analysis. J Alzheimers Dis 2012;31(2):253–258.
Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 2012;69(7):836–841.
Arlt S, Muller-Thomsen T, Beisiegel U, Kontush A. Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease. Neurochem Res 2012;37(12):2706–2714.
Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. Plos One 2010;5(9):e12244.
Douaud G, Refsum H, de Jager CA, Jacoby R, T EN, Smith SM, Smith AD. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 2013;110(23):9523–9528.
de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 2012;27(6):592–600.
Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, Ward V, Ames D, Masters CL, Bush AI. Homocysteine, vitamin B12, and folic acid levels in Alzheimer’s disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. J Alzheimers Dis 2011;27(4):909–922.
Ross AC. The 2011 report on dietary reference intakes for calcium and vitamin D. Public Health Nutr 2011;14(5):938–939.
Ross AC, Taylor CL, Yaktine AL, Del Vall HB. Dietary reference intakes for calcium and vitamin D. In: Nutrition IoMUFa, ed. Washington DC, 2011.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7):1911–1930.
Usoro OB, Mousa SA. Vitamin E Forms in Alzheimer’s Disease: A Review of Controversial and Clinical Experiences. Crit Rev Food Sci Nutr 2010;50(5):414–419.
Mangialasche F, Kivipelto M, Mecocci P, Rizzuto D, Palmer K, Winblad B, Fratiglioni L. High plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age. J Alzheimers Dis 2010;20(4):1029–1037.
Boothby LA, Doering PL. Vitamin C and vitamin E for Alzheimer’s disease. Ann Pharmacother 2005;39(12):2073–2080.
Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012(3):CD007176.
Smith A, Clark R, Nutt D, Haller J, Hayward S, Perry K. Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharmacol Clin Exp 1999;14(7):459–471.
Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr 2008;88(6):1602–1610.
Harrison FE. A Critical Review of Vitamin C for the Prevention of Age-Related Cognitive Decline and Alzheimer’s Disease. J Alzheimers Dis 2012;29(4):711–726.
Macready AL, Butler LT, Kennedy OB, Ellis JA, Williams CM, Spencer JPE. Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies. Nutr Res Rev 2010;23(2):200–229.
Stephan BCM, Minett T, Pagett E, Siervo M, Brayne C, McKeith IG. Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review. BMJ Open 2013;3(2).
Guallar ES, S., Mulrow, C., Appel, L.J. Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med 2013;159:850–851.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krause, D., Roupas, P. Effect of vitamin intake on cognitive decline in older adults: Evaluation of the evidence. J Nutr Health Aging 19, 745–753 (2015). https://doi.org/10.1007/s12603-015-0539-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-015-0539-3